Eli Lilly and Co. announced plans to spend $400 million for the expansion of its manufacturing capabilities at its Indianapolis campus. The expansion project will include added capacity for its diabetes medicines, improvements to its current facilities that produce insulin, and initial capital investments for future drugs and therapies to be developed.
Eli Lilly to invest $400M to expand manufacturing facilities
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.